6 completed, 2 unknown, 1 active not recruiting. 9 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 6, Unknown 2, Active not recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow ramosetron: new trials by email Literature Review of ramosetron trials Research Report on ramosetron
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal Incontinence Ramosetron, Psyllium - Fecal Incontinence | Phase 2 / Phase 3 | Active not recruiting | Seoul National University Hospital | 147 | 2024-01-19 | 2026-10-27 |
| Effect of Ramosetron in Prevention of Intrathecal Morphine Induced Nausea and Vomiting ramosetron, Ondansetron - Postoperative Nausea and Vomiting | Phase 3 | Completed | Thammasat University | 99 | 2014-04-01 | 2016-07-13 |
| Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy Ramosetron - Uterine Myoma, Ovary Neoplasm, Adenomyosis | Phase 3 | Unknown | National Health Insurance Service Ilsan Hospital | 128 | 2013-11-01 | 2013-12-13 |
| A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS) YM060, Placebo - Diarrhea-predominant Irritable Bowel Syndrome | Phase 3 | Completed | Astellas Pharma Inc | 577 | 2013-02-01 | 2015-10-12 |
| A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome YM060 - Diarrhea-predominant Irritable Bowel Syndrome | Phase 3 | Completed | Astellas Pharma Inc | 151 | 2012-09-01 | 2015-10-12 |
| Ramosetron, Aprepitant and Dexamethasone Versus Ondansetron, Aprepitant and Dexamethasone ramosetron, ondansetron - Cancer, Malignancy | Phase 3 | Unknown | Hallym University Medical Center | 338 | 2011-06-01 | 2012-10-03 |
| Ramosetron Versus Ondansetron for Radiotherapy Induced Nausea and Vomiting ramosetron, ondansetron - Radiotherapy Induced Nausea and Vomiting | Phase 3 | Completed | Seoul National University Hospital | 172 | 2009-09-01 | 2011-02-28 |
| A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea Ramosetron, Granisetron - Vomiting, Nausea | Phase 3 | Completed | Astellas Pharma Inc | 287 | 2006-01-01 | 2017-03-09 |
| Phase 3 Study of YM060 in Patients With Diarrhea-predominant Irritable Bowel Syndrome (d-IBS) YM060 - Irritable Bowel Syndrome | Phase 3 | Completed | Astellas Pharma Inc | 2015-10-12 |
Vomiting (4) · Postoperative Nausea and Vomiting (2) · Adenomyosis (1) · Diarrhea (1) · Fecal Incontinence (1) · Irritable Bowel Syndrome (1) · Myofibroma (1) · Nausea (1) · Neoplasms (1) · Ovarian Neoplasms (1)
Astellas Pharma Inc (4) · Seoul National University Hospital (2) · Hallym University Medical Center (1) · National Health Insurance Service Ilsan Hospital (1) · Thammasat University (1)
South Korea (4) · Japan (3) · Taiwan (1)
Rumi Shin, MD, PhD (1) · Sangwon Shin, M.D. (1)